Get the Stockscreener App
2.05
3.63%
0.096
Okyo Pharma Limited stock is traded at $2.05, with a volume of 9,796.
It is up +3.63% in the last 24 hours and down -5.81% over the past month.
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
See More
Previous Close:
$1.954
Open:
$1.99
24h Volume:
9,796
Relative Volume:
0.07
Market Cap:
$76.16M
Revenue:
-
Net Income/Loss:
$-13.27M
P/E Ratio:
-12.50
EPS:
-0.164
Net Cash Flow:
$-7.70M
1W Performance:
-0.74%
1M Performance:
-5.81%
6M Performance:
+89.25%
1Y Performance:
+96.60%
1-Day Range:
$1.9728
$2.05
1-Week Range:
$1.9036
$2.31
52-Week Range:
$0.9016
$3.349
Okyo Pharma Limited Stock (OKYO) Company Profile
Compare OKYO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OKYO
Okyo Pharma Limited
|
2.025 | 73.49M | 0 | -13.27M | -7.70M | -0.164 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.42 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.45 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.17 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.67 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
326.40 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Okyo Pharma Limited Stock (OKYO) Latest News
OKYO Pharma Limited’s volatility index tracking explainedMarket Activity Report & Target Return Focused Stock Picks - newser.com
How OKYO Pharma Limited stock valuations compare to rivalsInflation Watch & Target Return Focused Picks - newser.com
Is a relief rally coming for OKYO Pharma Limited holdersExit Point & Verified Short-Term Trading Plans - newser.com
What technical signals suggest for OKYO Pharma Limited stock2025 Historical Comparison & Long-Term Capital Growth Strategies - newser.com
OKYO Pharma (NASDAQ:OKYO) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat
Is OKYO Pharma Limited stock poised for growthTrade Ideas & Daily Stock Trend Reports - newser.com
Will OKYO Pharma Limited (OK11) stock sustain uptrend momentumWeekly Profit Recap & Fast Entry Momentum Trade Alerts - newser.com
Why analysts remain bullish on OKYO Pharma Limited stockMarket Growth Report & Reliable Price Action Trade Plans - newser.com
Will OKYO Pharma Limited (OK11) stock enhance shareholder valueJuly 2025 Decliners & Fast Exit and Entry Strategy Plans - newser.com
What analysts say about OKYO Pharma Limited stockStock Screening Results & Watch Expert Picks Before They Rally - earlytimes.in
OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO) Short Interest Update - Defense World
Is OKYO Pharma Limited stock a top momentum playTrade Entry Summary & Weekly Setup with ROI Potential - newser.com
What analysts say about OKYO Pharma Limited OK11 stockEx-Dividend Date Alerts & Avoid Market Traps With Pro-Level Warnings - earlytimes.in
What MACD and RSI say about OKYO Pharma LimitedJuly 2025 PostEarnings & Verified Short-Term Plans - newser.com
Statistical indicators supporting OKYO Pharma Limited’s strengthMarket Volume Summary & Safe Swing Trade Setup Alerts - newser.com
Is OKYO Pharma Limited (OK11) stock positioned for secular growth2025 Geopolitical Influence & Verified Momentum Stock Watchlist - newser.com
Using data filters to optimize entry into OKYO Pharma Limited2025 Big Picture & Advanced Swing Trade Entry Plans - newser.com
Published on: 2025-10-05 06:32:18 - newser.com
Why OKYO Pharma Limited stock attracts high net worth investorsJuly 2025 Spike Watch & Weekly Chart Analysis and Trade Guides - newser.com
Can OKYO Pharma Limited (OK11) stock expand revenue streamsJuly 2025 Setups & Safe Capital Allocation Plans - newser.com
Will OKYO Pharma Limited (OK11) stock announce a stock splitJuly 2025 Highlights & Growth Oriented Trade Recommendations - newser.com
Published on: 2025-10-05 03:34:35 - newser.com
Is OKYO Pharma Limited (OK11) stock cheap vs fundamentalsWeekly Market Outlook & Expert Curated Trade Setups - newser.com
Can OKYO Pharma Limited (OK11) stock sustain institutional flowsJuly 2025 PreEarnings & Reliable Breakout Stock Forecasts - newser.com
Published on: 2025-10-03 05:35:24 - newser.com
How OKYO Pharma Limited (OK11) stock reacts to Fed tightening2025 Price Targets & Breakout Confirmation Trade Signals - newser.com
How analysts rate OKYO Pharma Limited stock todayMarket Activity Report & Advanced Swing Trade Entry Plans - newser.com
Okyo Pharma Limited Stock (OKYO) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.20%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):